These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11960496)

  • 1. 5'-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N(6)-cyclopentyladenine: new adenosine A(1) receptor antagonists and inverse agonists.
    Van Calenbergh S; Link A; Fujikawa S; de Ligt RA; Vanheusden V; Golisade A; Blaton NM; Rozenski J; IJzerman AP; Herdewijn P
    J Med Chem; 2002 Apr; 45(9):1845-52. PubMed ID: 11960496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
    van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
    J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists.
    Van Calenbergh S; von Frijtag Drabbe Künzel JK; Blaton NM; Peeters OM; Rozenski J; Van Aerschot A; De Bruyn A; De Keukeleire D; IJzerman AP; Herdewijn P
    J Med Chem; 1997 Nov; 40(23):3765-72. PubMed ID: 9371242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
    Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA
    J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
    Harada H; Asano O; Hoshino Y; Yoshikawa S; Matsukura M; Kabasawa Y; Niijima J; Kotake Y; Watanabe N; Kawata T; Inoue T; Horizoe T; Yasuda N; Minami H; Nagata K; Murakami M; Nagaoka J; Kobayashi S; Tanaka I; Abe S
    J Med Chem; 2001 Jan; 44(2):170-9. PubMed ID: 11170626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
    Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
    Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Moro S; Spalluto G; Pastorin G; Da Ros T; Klotz KN; Varani K; Gessi S; Borea PA
    J Med Chem; 2002 Feb; 45(4):770-80. PubMed ID: 11831890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 1999 Nov; 42(22):4473-8. PubMed ID: 10579811
    [No Abstract]   [Full Text] [Related]  

  • 11. 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.
    de Zwart M; Kourounakis A; Kooijman H; Spek AL; Link R; von Frijtag Drabbe Künzel JK; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1384-92. PubMed ID: 10212124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Moro S; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2000 Dec; 43(25):4768-80. PubMed ID: 11123985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor.
    van Muijlwijk-Koezen JE; Timmerman H; van der Goot H; Menge WM; Frijtag Von Drabbe Künzel J; de Groote M; IJzerman AP
    J Med Chem; 2000 Jun; 43(11):2227-38. PubMed ID: 10841801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
    J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
    J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor.
    Kourounakis A; Visser C; de Groote M; IJzerman AP
    Biochem Pharmacol; 2001 Jan; 61(2):137-44. PubMed ID: 11163328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position.
    Ohno M; Gao ZG; Van Rompaey P; Tchilibon S; Kim SK; Harris BA; Gross AS; Duong HT; Van Calenbergh S; Jacobson KA
    Bioorg Med Chem; 2004 Jun; 12(11):2995-3007. PubMed ID: 15142558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.
    Hess S; Müller CE; Frobenius W; Reith U; Klotz KN; Eger K
    J Med Chem; 2000 Nov; 43(24):4636-46. PubMed ID: 11101355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.